Medigen Vaccine Biologics Tangible Net Worth Ratio

Latest as of June 2026: 100.0%

Medigen Vaccine Biologics tangible net worth ratio. Medigen Vaccine Biologics (6547) has a Tangible Net Worth Ratio of 100.0% as of June 2026. This metric is calculated by deducting intangible assets (NT$0.00) from net assets (NT$3.56 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check how strategically is Medigen Vaccine Biologics's equity deployed to assess the company's strategic physical and investment asset allocation.

Tangible NW Ratio

100.0%
Tangible equity / total equity

Net Assets (Equity)

NT$3.56 Billion
TWD

Intangible Assets

NT$0.00
Goodwill, patents, brand value

Total Assets

NT$4.76 Billion
TWD

Tangible Net Worth Ratio of Medigen Vaccine Biologics (2012–2025)

Tangible net worth ratio of Medigen Vaccine Biologics from 2012 to 2025. This chart shows how Medigen Vaccine Biologics's Tangible Net Worth Ratio has changed across 14 annual periods from 2012 to 2025. As of June 2026, the ratio stands at 100.0%, reflecting net assets of NT$3.56 Billion with intangible assets of NT$0.00 TWD. See Medigen Vaccine Biologics short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.

Medigen Vaccine Biologics Tangible Net Worth Ratio by Year (2012–2025)

Medigen Vaccine Biologics tangible net worth ratio by year from 2012 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for Medigen Vaccine Biologics from 2012 to 2025, covering 14 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see 6547 market cap.

Year Tangible NW Ratio Net Assets (TWD) Intangible Assets Total Assets Change (pp)
2025 99.4% NT$3.48 Billion NT$21.14 Million NT$3.93 Billion ▲ +0.2 pp
2024 99.2% NT$3.85 Billion NT$29.38 Million NT$4.36 Billion ▲ +0.2 pp
2023 99.0% NT$3.85 Billion NT$38.30 Million NT$6.09 Billion ▼ -0.1 pp
2022 99.1% NT$5.03 Billion NT$45.36 Million NT$7.35 Billion ▲ +0.2 pp
2021 98.9% NT$4.68 Billion NT$52.98 Million NT$5.30 Billion ▲ +0.8 pp
2020 98.1% NT$3.14 Billion NT$60.01 Million NT$3.49 Billion ▲ +2.6 pp
2019 95.5% NT$1.37 Billion NT$61.81 Million NT$2.28 Billion ▼ -0.2 pp
2018 95.7% NT$1.61 Billion NT$69.69 Million NT$2.18 Billion ▲ +0.8 pp
2017 94.9% NT$1.52 Billion NT$77.66 Million NT$2.14 Billion ▲ +0.4 pp
2016 94.5% NT$1.47 Billion NT$80.53 Million NT$1.82 Billion ▲ +1.0 pp
2015 93.5% NT$1.34 Billion NT$87.67 Million NT$1.65 Billion ▲ +2.3 pp
2014 91.2% NT$1.08 Billion NT$95.29 Million NT$1.21 Billion ▲ +11.2 pp
2013 80.0% NT$457.94 Million NT$91.69 Million NT$477.40 Million ▲ +56.8 pp
2012 23.1% NT$128.00 Million NT$98.38 Million NT$150.15 Million —
pp = percentage points